Lantern Pharma Inc. [LTRN]

Source: 

Company Overview

We are a clinical stage biotechnologycompany, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drugdevelopment process and to identify the patients that will benefit from our targeted oncology therapies. Our portfolio of therapies consistsof small molecules that others have tried, but failed, to develop into an approved commercialized drug, as well as new compounds thatwe are developing with the assistance of our proprietary A.I. platform and our biomarker driven approach.